You read my mind.
Interested in this question too
Just compounding. FDA has no control over the clandestine APIs being pumped out by Chinese labs. And customs already looks for and seizes gray market peps that they find during random searches.
I'm pretty new to this particular industry, but that was a tempest in a teapot if I ever saw one. One of my domestics that was priced pretty reasonably before that got too big for their britches, raised their prices too much ~50% for my preferred GLP in 2 months), and lost my business (or at least any GLP portion of it, they're fine for singles of certain things). So this trend seems to be that domestics are raising their prices while CNs are coming down with theirs, and also responding well to market demands to open up US warehouses so that people can avoid customs hassles and potential for losing Global Entry privileges, etc. I was pretty predisposed to and in the process of moving toward CN anyway, but faced with a~5-10% premium for a CN company with a US warehouse vs. paying through the nose with a domestic reseller, the choice was pretty easy.
Oh please protect us from weight loss, lowered A1C, and increased health, FDA. What would we do without you? /sFDA Intends to Take Action Against Non-FDA-Approved GLP-1 Drugs
Today, the U.S. Food and Drug Administration is announcing its intent to take decisive steps to restrict GLP-1 active pharmaceutical ingredients (APIs) intended for use in non-FDA-approved compounded drugs that are being mass-marketed by companieswww.fda.gov
Agreed! I've got 10 years worth at a mid dose in the deep freezer... seriously considering making that 10 years worth at 15mg/week. If I have to buy even one month worth direct from Lily, that equates to like 2 years worth on grey. 10 years worth sounds insane but that is cheap insurance since I plan to use it for the rest of my life. Plus it's just kinda fun buying it for some strange reason lol.
It's an annual migration
At least the troglodytes at r/retatrutide haven't migrated here.
Living proof that Darwin was right.
I suspect direct to researcher grey is still a very small consumer of these peptides, overall.
I have about a year of compound Tirzepatide to work through and the fearmongering is real. I'm debating buying a bunch of grey kits after seeing this article. Seems like something similar happened last year and cause the same type of panic so that's keeping me at bay currently haha
That sub is insufferable. A mix of "Look at me" spam by bodybuilder bros, and straight up bro science medical advice.
I'm still working through all the tirz I bought in the "Great Panic of 2024" 🤣 Back in the days when $220 for a kit of T30 was a good deal....
I had to quit it to preserve my sanity. I counted 13 overdoses one week. "But I only took 20 units!!"
I proudly worship at the Church of randompersonrandom. And I don't even believe in Jebus.
The 'roid rage is real there, for sure.
When I start a cult, it's gonna be awful. I mean, it'll be fine for the first ten years, but when we run out of GLP-1's, we'll all eat each other.
Good old bro science. 50% fact, 50% magic, and 100% results XD
I like the posts where the Bro is sweating uncontrollably, can't eat or sleep and possibly bleeding from their eye sockets and someone asks what their stack is and they list 9 things. The sheer entertainment value is worth it.
The more I read about this and the previous similar news stories the more its about big time domestic compounders/med spas/wellness pharmacies. Nothing to do with real grey. Like this story is basically directed at HIMS/HERS. I don't think anyone cares about china/grey market.
This is my take too. You don’t give them enough credit though EL is a trillion dollar company. They blamed a recent quarter when they didn’t hit their earnings targets on compounding. I don’t believe the vast majority of those people will be able to afford EL prices if they get compounding shut down, which they will at some point. Those people will find grey or quit taking the drug. Grey will just be the next whack-a-mole they target when they still don’t hit earnings.
